1. Home
  2. REFR vs NTRB Comparison

REFR vs NTRB Comparison

Compare REFR & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REFR
  • NTRB
  • Stock Information
  • Founded
  • REFR 1965
  • NTRB 2016
  • Country
  • REFR United States
  • NTRB United States
  • Employees
  • REFR N/A
  • NTRB N/A
  • Industry
  • REFR Multi-Sector Companies
  • NTRB Industrial Specialties
  • Sector
  • REFR Miscellaneous
  • NTRB Health Care
  • Exchange
  • REFR Nasdaq
  • NTRB Nasdaq
  • Market Cap
  • REFR 56.6M
  • NTRB 46.4M
  • IPO Year
  • REFR N/A
  • NTRB N/A
  • Fundamental
  • Price
  • REFR $1.66
  • NTRB $4.11
  • Analyst Decision
  • REFR
  • NTRB
  • Analyst Count
  • REFR 0
  • NTRB 0
  • Target Price
  • REFR N/A
  • NTRB N/A
  • AVG Volume (30 Days)
  • REFR 24.8K
  • NTRB 26.3K
  • Earning Date
  • REFR 03-06-2025
  • NTRB 12-04-2024
  • Dividend Yield
  • REFR N/A
  • NTRB N/A
  • EPS Growth
  • REFR N/A
  • NTRB N/A
  • EPS
  • REFR N/A
  • NTRB N/A
  • Revenue
  • REFR $1,469,616.00
  • NTRB $2,021,771.00
  • Revenue This Year
  • REFR N/A
  • NTRB N/A
  • Revenue Next Year
  • REFR N/A
  • NTRB N/A
  • P/E Ratio
  • REFR N/A
  • NTRB N/A
  • Revenue Growth
  • REFR 102.07
  • NTRB N/A
  • 52 Week Low
  • REFR $0.93
  • NTRB $2.22
  • 52 Week High
  • REFR $2.41
  • NTRB $9.60
  • Technical
  • Relative Strength Index (RSI)
  • REFR 42.72
  • NTRB 44.78
  • Support Level
  • REFR $1.62
  • NTRB $3.90
  • Resistance Level
  • REFR $1.70
  • NTRB $5.16
  • Average True Range (ATR)
  • REFR 0.10
  • NTRB 0.33
  • MACD
  • REFR 0.01
  • NTRB -0.01
  • Stochastic Oscillator
  • REFR 37.50
  • NTRB 27.04

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. Its revenue source comes from the licensing of technology.

About NTRB Nutriband Inc.

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Share on Social Networks: